Risk Factors of Arterial Events in Patients with Venous Thromboembolism: A Systematic Review and Meta-Analysis

被引:5
|
作者
Noumegni, Steve Raoul [1 ,2 ]
Hoffmann, Clement [1 ,2 ]
Tromeur, Cecile [2 ,3 ]
Didier, Romain [3 ,4 ]
Bressollette, Luc [1 ,2 ]
Lacut, Karine [2 ,3 ]
Couturaud, Francis [2 ,3 ]
机构
[1] Brest Univ, Brest Teaching Hosp, Vasc Med Dept, Brest, France
[2] Brest Univ, Grp Etud Thrombose Bretagne Occidentale, EA3878 GETBO, Brest, France
[3] Brest Univ, Brest Teaching Hosp, Internal Med & Pneumol Dept, Brest, France
[4] Brest Univ, Brest Teaching Hosp, Cardiol Dept, Brest, France
关键词
arterial events; cardiovascular disease; venous thromboembolism; risk factor; meta-analysis; PATENT FORAMEN OVALE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; PULMONARY-EMBOLISM; VEIN-THROMBOSIS; ISCHEMIC-STROKE; 1ST EPISODE; DISEASE; IMPACT; MORTALITY;
D O I
10.1055/s-0041-1732300
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background If recent studies suggested that arterial ischemic events in patients with venous thromboembolism (VTE) are more frequent than in the general population without VTE, whether patients with VTE have different risk factors of arterial events than classic known cardiovascular risk factors remain undefined. Through this systematic review and meta-analysis, we aimed to identify risk factors of arterial ischemic events in patients with VTE. Methods We searched PubMed, EMBASE, and Cochrane databases to identify cohort studies published between January 1, 2000, and December 31, 2020, reporting risk factors of arterials ischemic events in patients with VTE. Random-effect models meta-analysis served to get the pooled hazard ratio (HR) and 95% confidence interval (CI) of each risk factor identified. Results We screened 1,467 records of which 18 were finally included in systematic review and 10 in meta-analyses. Adjusted HR for 9 factors were included in meta-analysis. Male gender (HR: 1.38; 95% CI: 1.28-1.49), diabetes (HR: 1.65; 95% CI: 1.28-2.12), hypertension (HR: 1.38; 95% CI: 1.04-1.84), previous atherothrombotic event (HR: 3.22; 95% CI: 1.12-9.23), chronic kidney disease (HR: 1.41; 95% CI: 1.05-1.88), cancer (HR: 1.72; 95% CI: 1.41-2.09), and unprovoked VTE (HR: 1.88; 95% CI: 1.37-2.57) were the identified risk factors of arterial events in VTE population after meta-analysis. Conclusion Risk factors of arterial events in patients with VTE include usual cardiovascular risk factors and other risk factors that are related to VTE such as cancer and unprovoked VTE.
引用
收藏
页码:590 / 599
页数:10
相关论文
共 50 条
  • [21] Travel and the Risk of Venous Thromboembolism: A Systematic Review and Meta-analysis
    Chandra, Divay
    Parisini, Emilio
    Mozaffarian, Dariush
    CIRCULATION, 2009, 119 (10) : E341 - E341
  • [22] SARCOIDOSIS AND RISK OF VENOUS THROMBOEMBOLISM: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Ungprasert, Patompong
    Srivali, Narat
    Wijarnpreecha, Karn
    Thongprayoon, Charat
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (03) : 182 - 187
  • [23] Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis
    Ungprasert, Patompong
    Sanguankeo, Anawin
    Upala, Sikarin
    Suksaranjit, Promporn
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2014, 107 (10) : 793 - 797
  • [24] Incidence and risk factors for postoperative venous thromboembolism in patients with ovarian cancer: Systematic review and meta-analysis
    Xu, Yu
    Jia, Ya
    Zhang, Qianwen
    Du, Yi
    He, Yuedong
    Zheng, Ai
    GYNECOLOGIC ONCOLOGY, 2021, 160 (02) : 610 - 618
  • [25] Risk factors for venous thromboembolism after hip arthroscopy: a systematic review and meta-analysis
    Li, Haoxuan
    Zhang, Huan
    Zhou, Shengjie
    Hu, Chaowei
    Guan, Yiyuan
    Jin, Ri
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2025, 20 (01):
  • [26] Risk Factors of Venous Thromboembolism in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Zhang, Hua
    Wang, Xuehong
    FRONTIERS IN MEDICINE, 2021, 8
  • [27] Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis
    Qi, Wei-Xiang
    Lin, Feng
    Sun, Yuan-Jue
    Tang, Li-Na
    Shen, Zan
    Yao, Yang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (03) : 338 - 347
  • [28] Risk Factors of Venous Thromboembolism in Lymphoma Patients: A Meta-Analysis
    Jiang, Cuiting
    Lv, Jing
    Liu, Tingting
    Liu, Yao
    BLOOD, 2023, 142
  • [29] The risk of venous thromboembolism in cancer patients receiving chemotherapy: a meta-analysis with systematic review
    Bao, Yun
    Wan, Xu
    Fu, Jie
    Wu, Bin
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (04)
  • [30] Risk of venous thromboembolism in pregnant patients with active malignancy: A systematic review and meta-analysis
    Folkins, Sara
    Miller, Ashley
    Nash, Christopher M.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2024, 103 (04) : 645 - 652